Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Dick

Showing results (41-50 of 178) with videos related to

Pageof 18
Sort By:
Frontiers in Microbiology|November 16, 2020
Indole Propionic Acid, an Unusual Antibiotic Produced by the Gut Microbiota, With Anti-inflammatory and Antioxidant PropertiesDereje Abate Negatu, Martin Gengenbacher, Véronique Dartois, et al.
The European Respiratory Journal|May 2, 2024
Rifampicin has no role in treatment of <i>Mycobacterium avium</i> complex pulmonary disease and bactericidal sterilising drugs are needed: a viewpointJakko van Ingen, Wouter Hoefsloot, Véronique Dartois, et al.
Tuberculosis (Edinburgh, Scotland)|December 3, 2014
Future target-based drug discovery for tuberculosis?Bavesh Davandra Kana, Petros C Karakousis, Tanya Parish, et al.
FEMS Microbiology Letters|August 6, 2008
Biochemical and structural characterization of the putative dihydropteroate synthase ortholog Rv1207 of Mycobacterium tuberculosisMartin Gengenbacher, Ting Xu, Pornwaratt Niyomrattanakit, et al.
Drug Discovery Today|April 11, 2018
NTM drug discovery: status, gaps and the way forwardMu-Lu Wu, Dinah B Aziz, Véronique Dartois, et al.
Microbiology Spectrum|July 17, 2023
Characterization of <i>In Vitro</i> Resistance to Linezolid in Mycobacterium abscessusDereje A Negatu, Wassihun Wedajo Aragaw, Véronique Dartois, et al.
Frontiers in Microbiology|March 21, 2020
Extreme Drug Tolerance of <i>Mycobacterium abscessus</i> "Persisters"Yee-Kuen Yam, Nadine Alvarez, Mei-Lin Go, et al.
Antimicrobial Agents and Chemotherapy|September 22, 2020
Resistance against Membrane-Inserting MmpL3 Inhibitor through Upregulation of MmpL5 in Mycobacterium tuberculosisMing Li, Samuel Agyei Nyantakyi, Mei-Lin Go, et al.
Future Microbiology|May 10, 2016
Membrane-targeting AM-0016 kills mycobacterial persisters and shows low propensity for resistance developmentDevika Mukherjee, Hanxun Zou, Shouping Liu, et al.
Biochemical and Biophysical Research Communications|November 26, 2019
Overexpression, purification, enzymatic and microscopic characterization of recombinant mycobacterial F-ATP synthaseWuan-Geok Saw, Chui-Fann Wong, Thomas Dick, et al.
Pageof 18

Showing results (41-50 of 178) with videos related to

Sort By:
Pageof 18
Frontiers in Microbiology|November 16, 2020
Indole Propionic Acid, an Unusual Antibiotic Produced by the Gut Microbiota, With Anti-inflammatory and Antioxidant PropertiesDereje Abate Negatu, Martin Gengenbacher, Véronique Dartois, et al.
The European Respiratory Journal|May 2, 2024
Rifampicin has no role in treatment of <i>Mycobacterium avium</i> complex pulmonary disease and bactericidal sterilising drugs are needed: a viewpointJakko van Ingen, Wouter Hoefsloot, Véronique Dartois, et al.
Tuberculosis (Edinburgh, Scotland)|December 3, 2014
Future target-based drug discovery for tuberculosis?Bavesh Davandra Kana, Petros C Karakousis, Tanya Parish, et al.
FEMS Microbiology Letters|August 6, 2008
Biochemical and structural characterization of the putative dihydropteroate synthase ortholog Rv1207 of Mycobacterium tuberculosisMartin Gengenbacher, Ting Xu, Pornwaratt Niyomrattanakit, et al.
Drug Discovery Today|April 11, 2018
NTM drug discovery: status, gaps and the way forwardMu-Lu Wu, Dinah B Aziz, Véronique Dartois, et al.
Microbiology Spectrum|July 17, 2023
Characterization of <i>In Vitro</i> Resistance to Linezolid in Mycobacterium abscessusDereje A Negatu, Wassihun Wedajo Aragaw, Véronique Dartois, et al.
Frontiers in Microbiology|March 21, 2020
Extreme Drug Tolerance of <i>Mycobacterium abscessus</i> "Persisters"Yee-Kuen Yam, Nadine Alvarez, Mei-Lin Go, et al.
Antimicrobial Agents and Chemotherapy|September 22, 2020
Resistance against Membrane-Inserting MmpL3 Inhibitor through Upregulation of MmpL5 in Mycobacterium tuberculosisMing Li, Samuel Agyei Nyantakyi, Mei-Lin Go, et al.
Future Microbiology|May 10, 2016
Membrane-targeting AM-0016 kills mycobacterial persisters and shows low propensity for resistance developmentDevika Mukherjee, Hanxun Zou, Shouping Liu, et al.
Biochemical and Biophysical Research Communications|November 26, 2019
Overexpression, purification, enzymatic and microscopic characterization of recombinant mycobacterial F-ATP synthaseWuan-Geok Saw, Chui-Fann Wong, Thomas Dick, et al.
Pageof 18